New Arrivals
Chemical Structure | Cat. No. | Product Name | CAS No. |
---|
BCP49707 | Quinacrine dihydrochloride New | 69-05-6 | |
Quinacrine (Mepacrine) dihydrochloride is an orally bioavailable antimalarial agent, which possess anticancer effect both in vitro and vivo. Quinacrine dihydrochloride suppresses NF-κB and activate p53 signaling, which results in the induction of the apoptosis.
|
BCP49706 | Nicarbazin New | 330-95-0 | |
Nicarbazin is an effective anticoccidial agent for chickens.
|
BCP49705 | Oxibendazole New | 20559-55-1 | |
Oxibendazole is an effective benzimidazole anthelmintic and is against nema-tode infections. Oxibendazole can induces apoptosis and has anti-cancer and anti-inflammation activities.
|
BCP49704 | Stibogluconate sodium New | 16037-91-5 | |
Sodium stibogluconate is a pentavalent antimony compound. It exhibits protein tyrosine phosphatase (PTPase) activity.
|
BCP49703 | Bromotrimethylsilane New | 2857-97-8 |
BCP49701 | (22S,64S,4S)-4-amino-12-(5-(4-cyclopropylpiperazin-1-yl)-2-((S)-1-methoxyethyl)pyridin-3-yl)-10,10-dimethyl-11-(2,2,2-trifluoroethyl)-11H-8-oxa-62,63- New | 123456789-01-7 |
BCP49702 | Lithium(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carboxylate New | 2864383-31-1 |
BCP49700 | 2,3-Diazabicyclo[3.1.1]heptane-4-carboxylic acid, methyl ester, (4S)- New | 3034241-21-6 |
BCP28639 | Mutated EGFR-IN-1 New | 1421372-66-8 | |
Mutated EGFR-IN-1 is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant and T790M resistance mutant.
|
BCP49699 | Sevabertinib New | 2521285-05-0 | |
Sevabertinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with antitumor activity.
|
BCP49698 | CMP-5 dihydrochloride New | 2309409-79-6 | |
CMP-5 hydrochloride is a potent and selective PRMT5 inhibitor, while displays no activity against PRMT1/4/7 enzymes. It selectively blocks S2Me-H4R3 by inhibiting PRMT5 methyltransferase activity on histone preparations.
|
BCP49697 | CBD3063 New | 1281060-70-5 | |
CBD3063 is a selective, first-in-class, CRMP2-based peptidomimetic small molecule, which allosterically regulates Cav2.2 to achieve analgesia and pain relief without negative side effect profiles.
|
BCP49696 | Pogostone New | 23800-56-8 | |
Pogostone is isolated from mint and has antibacterial and anticancer activities. Pogostone inhibited gram-negative bacteria and Gram-positive bacteria, and also showed inhibitory effect on Bacillus sclericae, with MIC value of 0.098 µg/mL. Pogostone can induce apoptosis and autophagy.
|
BCP49694 | (2S)-2-cyclopentyl-2-[(5S)-2-[(2-methylpropan-2-yl)oxycarbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]acetic acid New | 2865128-45-4 |
BCP49695 | Tafluprost 16 E-diene New | T16ED |
BCP49693 | Cefixime Dimer D New | CDD |
BCP49692 | (S)-3-[(S)-4-Boc-吗啉-2-基]-2-(Cbz-氨基)丙酸甲酯 New | 2641824-60-2 |
BCP49691 | 5-Bromo-3-(3-((tert-butyldiphenylsilyl)oxy)-2,2-dimethylpropyl)-2-iodo-1H-indole New | 2641451-43-4 |
BCP49689 | KRAS G12D inhibitor 18 New | 2922732-54-3 | |
KRAS G12D inhibitor 18 is a potent KRAS G12D inhibitor.
|
BCP49690 | Tromethamine hydrochloride New | 1185-53-1 | |
Trometamol hydrochloride is a biologically inert amino alcohol of low toxicity, which buffers carbon dioxide and acids in vitro and in vivo. Trometamol hydrochloride is an effective amine compound for pH control in the physiological range.
|